Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Barros

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Psychopharmacology|June 14, 2023
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis RegistryRaphael Rifkin-Zybutz, Simon Erridge, Carl Holvey, et al.
Natural Product Research|September 15, 2023
<i>In vitro</i> micropropagation and tiliroside production in <i>Paratecoma peroba</i> (Record) Kuhlm, an endemic and endangered Brazilian treeLarissa Zambe Pinheiro, Carolina Chaves Ramos, Daniela Barros de Oliveira, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2021
The component of the m<sup>6</sup>A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, et al.
Expert Review of Neurotherapeutics|December 12, 2022
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis RegistryManaswini Pillai, Simon Erridge, Lara Bapir, et al.
Cell Death & Disease|February 9, 2018
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesisDaniela Barros-Silva, Pedro Costa-Pinheiro, Henrique Duarte, et al.
Cancer Cell International|June 6, 2019
Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotypeTânia Soraia Vieira-Silva, Sara Monteiro-Reis, Daniela Barros-Silva, et al.
Cancers|October 14, 2020
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell TumorsJoão Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, et al.
Life Science Alliance|January 14, 2021
Proteostasis in dendritic cells is controlled by the PERK signaling axis independently of ATF4Andreia Mendes, Julien P Gigan, Christian Rodriguez Rodrigues, et al.
Cancer Research|October 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA MethylationÓscar Monteagudo-García, Paz Nombela, Ángel Carlos Román, et al.
Cellular & Molecular Biology Letters|January 24, 2026
VPS34-IN1 potentiates STING-dependent activation in human CAL-1 cellsPaulo Antas, Mariana D Machado, Fátima Leite-Pinheiro, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Psychopharmacology|June 14, 2023
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis RegistryRaphael Rifkin-Zybutz, Simon Erridge, Carl Holvey, et al.
Natural Product Research|September 15, 2023
<i>In vitro</i> micropropagation and tiliroside production in <i>Paratecoma peroba</i> (Record) Kuhlm, an endemic and endangered Brazilian treeLarissa Zambe Pinheiro, Carolina Chaves Ramos, Daniela Barros de Oliveira, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2021
The component of the m<sup>6</sup>A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, et al.
Expert Review of Neurotherapeutics|December 12, 2022
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis RegistryManaswini Pillai, Simon Erridge, Lara Bapir, et al.
Cell Death & Disease|February 9, 2018
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesisDaniela Barros-Silva, Pedro Costa-Pinheiro, Henrique Duarte, et al.
Cancer Cell International|June 6, 2019
Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotypeTânia Soraia Vieira-Silva, Sara Monteiro-Reis, Daniela Barros-Silva, et al.
Cancers|October 14, 2020
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell TumorsJoão Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, et al.
Life Science Alliance|January 14, 2021
Proteostasis in dendritic cells is controlled by the PERK signaling axis independently of ATF4Andreia Mendes, Julien P Gigan, Christian Rodriguez Rodrigues, et al.
Cancer Research|October 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA MethylationÓscar Monteagudo-García, Paz Nombela, Ángel Carlos Román, et al.
Cellular & Molecular Biology Letters|January 24, 2026
VPS34-IN1 potentiates STING-dependent activation in human CAL-1 cellsPaulo Antas, Mariana D Machado, Fátima Leite-Pinheiro, et al.
Pageof 7